Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Cytotoxicity of dendrimers
A Janaszewska, J Lazniewska, P Trzepiński… - Biomolecules, 2019 - mdpi.com
Drug delivery systems are molecular platforms in which an active compound is packed into
or loaded on a biocompatible nanoparticle. Such a solution improves the activity of the …
or loaded on a biocompatible nanoparticle. Such a solution improves the activity of the …
[HTML][HTML] Dendrimers in the context of nanomedicine
Dendrimers are globular structures, presenting an initiator core, repetitive layers starting
radially from the core and terminal groups on the surface, resembling tree architecture …
radially from the core and terminal groups on the surface, resembling tree architecture …
Overcoming the blood–brain barrier. challenges and tricks for CNS drug delivery
Treatment of certain central nervous system disorders, including different types of cerebral
malignancies, is limited by traditional oral or systemic administrations of therapeutic drugs …
malignancies, is limited by traditional oral or systemic administrations of therapeutic drugs …
[HTML][HTML] Dendrimer-based drug delivery systems for brain targeting
Human neuroscience has made remarkable progress in understanding basic aspects of
functional organization; it is a renowned fact that the blood–brain barrier (BBB) impedes the …
functional organization; it is a renowned fact that the blood–brain barrier (BBB) impedes the …
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
Alzheimer's disease (AD) is a neurodegenerative disease with high prevalence in the
rapidly growing elderly population in the develo** world. The currently FDA approved …
rapidly growing elderly population in the develo** world. The currently FDA approved …
siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disease with a few FDA-
approved drugs that provide modest symptomatic benefits and only two FDA-approved …
approved drugs that provide modest symptomatic benefits and only two FDA-approved …
Dendrimers and hyperbranched structures for biomedical applications
The use of nanotechnology in biology and medicine has been marked by rapid progress of
these industries due to the emergence of new devices, supramolecular systems, structures …
these industries due to the emergence of new devices, supramolecular systems, structures …
Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
A brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that
grow and divide abnormally and appear to be uncontrollable by the processes that normally …
grow and divide abnormally and appear to be uncontrollable by the processes that normally …
Molecular insights into the phase transition of lysozyme into amyloid nanostructures: Implications of therapeutic strategies in diverse pathological conditions
Lysozyme, a well-known bacteriolytic enzyme, exhibits a fascinating yet complex behavior
when it comes to protein aggregation. Under certain conditions, this enzyme undergoes …
when it comes to protein aggregation. Under certain conditions, this enzyme undergoes …
Dendrimer advances for the central nervous system delivery of therapeutics
The effectiveness of noninvasive treatment for central nervous system (CNS) diseases is
generally limited by the poor access of therapeutic agents into the CNS. Most CNS drugs …
generally limited by the poor access of therapeutic agents into the CNS. Most CNS drugs …